SCHEMBL9703598

SCHEMBL9703598

COc1cc(S(C)(=O)=O)ccc1-c1nc2cc3c(cc2[nH]1)C(C)(C)CC(=O)N3

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.41
CCNA2 P20248 1/20 0.41
CCND1 P24385 1/20 0.41
CDK2 P24941 1/20 0.41
CCND3 P30281 1/20 0.41
SCD O00767 8/20 0.39
NPBWR1 P48145 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
AMY1A P0DUB6 1/20 0.37
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
CBFB Q13951 1/20 0.36
FADS1 O60427 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9383099 0.85 AMY1A (0.47) NPBWR1PDE4APDE4BPDE4CPDE4D
SCHEMBL9382509 0.84 PDE5A (0.46) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL9382455 0.82 ALDH1A1 (0.39) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL10373442 0.82 PDE3B (0.48) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9383861 0.81 CDK4 (0.41) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9704446 0.79 CDK4 (0.42) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9703335 0.78 CDK4 (0.47) CDK4CCNA2CCND1CDK2CCND3
SCHEMBL9379939 0.76 PDE4A (0.48) SCDNPBWR1PDE4APDE4BPDE4C
SCHEMBL9704491 0.76 PDE4A (0.48) SCDNPBWR1PDE4APDE4BPDE4C
SCHEMBL9379025 0.76 NPC1 (0.50) NPBWR1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed